X

Quest Diagnostics (DGX) Q3 2019 Earnings Snapshot

— Quest Diagnostics (NYSE: DGX) reported third quarter 2019 adjusted EPS of $1.76 vs. $1.71 expected.

Check below Quest Diagnostics Q3 2019 earnings infograph

— GAAP EPS of continuing operations increased 2.8% year-over-year to $1.56.

— Revenue grew 3.5% to $1.96 billion vs. $1.94 billion expected.

— Diagnostic Information Services revenue grew 3.7% to $1.88 billion.

— For fiscal 2019, revenue is expected to be approximately $7.72 billion.

— FY19 adjusted EPS is pegged to be between $6.45 and $6.50. Reported EPS from continuing operations is touted to be $5.48-5.43.

— DGX stock, which reached its 52-week high on Sept. 20, inched down 0.37% to $102.28 yesterday.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Related Post